Amgen Financial Statements From 2010 to 2024

AMG Stock   255.90  7.15  2.87%   
Amgen financial statements provide useful quarterly and yearly information to potential Amgen Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Amgen financial statements helps investors assess Amgen's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Amgen's valuation are summarized below:
Amgen Inc does not presently have any fundamental signals for analysis.
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as , as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.

Amgen Inc Company Current Valuation Analysis

Amgen's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Amgen Current Valuation

    
  163.09 B  
Most of Amgen's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amgen Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Amgen Inc has a Current Valuation of 163.09 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers-General industry. The current valuation for all Germany stocks is significantly lower than that of the firm.

Amgen Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Amgen's current stock value. Our valuation model uses many indicators to compare Amgen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amgen competition to find correlations between indicators driving Amgen's intrinsic value. More Info.
Amgen Inc is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers reporting about  0.08  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amgen Inc is roughly  12.69 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amgen's earnings, one of the primary drivers of an investment's value.

About Amgen Financial Statements

Amgen shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Amgen investors may analyze each financial statement separately, they are all interrelated. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses on on Amgen's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Amgen Stock Analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.